Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axonics Inc
(NQ:
AXNX
)
70.98
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Axonics Inc
< Previous
1
2
3
Next >
Axonics Reports Third Quarter 2024 Financial Results
November 07, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
September 26, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
September 18, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Second Quarter 2024 Financial Results
August 01, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
May 16, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports First Quarter 2024 Financial Results
April 30, 2024
From
Axonics, Inc.
Via
Business Wire
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
April 30, 2024
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.
Via
MarketBeat
Axonics Stockholders Approve Merger Agreement with Boston Scientific
March 22, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
March 14, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Responds to ITC Action by Medtronic
February 29, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 28, 2024
From
Axonics, Inc.
Via
Business Wire
AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
February 27, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 16, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
January 08, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders
January 08, 2024
From
Halper Sadeh LLC
Via
Business Wire
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
January 08, 2024
From
Axonics, Inc.
Via
Business Wire
Axonics to Present at the J.P. Morgan Healthcare Conference
December 27, 2023
From
Axonics, Inc.
Via
Business Wire
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
November 06, 2023
From
NeuroQure
Via
GlobeNewswire
Axonics to Participate in November Investor Conferences
November 01, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Third Quarter 2023 Financial Results
October 30, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Report Third Quarter 2023 Financial Results on October 30
October 02, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Participate in September Investor Conferences
August 25, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Announces CFO Retirement and Appoints Successor
August 21, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Reports Second Quarter 2023 Financial Results
July 27, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Report Second Quarter 2023 Financial Results on July 27
June 29, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Reports First Quarter 2023 Financial Results
May 01, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Participate in Upcoming Investor Conferences
April 25, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics Acquires Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
April 24, 2023
From
Axonics, Inc.
Via
Business Wire
Axonics to Report First Quarter 2023 Financial Results on May 1
April 10, 2023
From
Axonics, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
